|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Ambien
|
|
gptkbp:appointed_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Ambien
gptkb:Edluar
gptkb:Intermezzo
|
|
gptkbp:class
|
sedative-hypnotic
imidazopyridine
|
|
gptkbp:contraindication
|
gptkb:Insurance_Company
sleep apnea
severe liver impairment
|
|
gptkbp:dependency
|
low
|
|
gptkbp:developed_by
|
Searle
|
|
gptkbp:dosage_form
|
10 mg
5 mg
extended-release tablet
oral spray
|
|
gptkbp:duration
|
short-term use
|
|
gptkbp:education
|
take on an empty stomach
avoid driving after use
do not mix with alcohol
|
|
gptkbp:effective_date
|
gptkb:1992
|
|
gptkbp:established
|
flumazenil
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:first_introduced
|
gptkb:1993
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
zolpidem tartrate
|
|
gptkbp:ingredients
|
C19 H21 N3 O
|
|
gptkbp:interacts_with
|
gptkb:beer
antihistamines
antidepressants
CNS depressants
|
|
gptkbp:is_available_on
|
generic
|
|
gptkbp:is_monitored_by
|
gptkb:battle
|
|
gptkbp:is_used_for
|
insomnia
|
|
gptkbp:is_used_to
|
gptkb:theorem
|
|
gptkbp:lifespan
|
2.5 hours
|
|
gptkbp:manager
|
sublingual
|
|
gptkbp:marketed_as
|
gptkb:Sanofi
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
drowsiness
|
|
gptkbp:sleeping_habits
|
reduces sleep latency
increases sleep duration
|
|
gptkbp:suitable_for
|
gptkb:Person
pregnant women
breastfeeding women
|
|
gptkbp:symptoms
|
rare
confusion
respiratory depression
coma
|